(NYSE: EW) Edwards Lifesciences's forecast annual revenue growth rate of 6.9% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.54%.
Edwards Lifesciences's revenue in 2023 is $5,819,000,000.On average, 12 Wall Street analysts forecast EW's revenue for 2023 to be $3,618,079,974,000, with the lowest EW revenue forecast at $3,610,548,000,000, and the highest EW revenue forecast at $3,636,606,000,000. On average, 12 Wall Street analysts forecast EW's revenue for 2024 to be $3,939,762,348,000, with the lowest EW revenue forecast at $3,905,124,600,000, and the highest EW revenue forecast at $3,968,850,954,000.
In 2025, EW is forecast to generate $4,318,703,844,000 in revenue, with the lowest revenue forecast at $4,194,126,000,000 and the highest revenue forecast at $4,381,986,000,000.